TANVEER HUSSAIN: Open Payments
NPI 1114916202 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 32 payments from 11 companies in 2025. Trend: 2023 $1,039 · 2024 $928 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 6 | $103 |
| Supernus Pharmaceuticals, Inc. | 6 | $100 |
| Corium, LLC | 3 | $85 |
| Neos Therapeutics, LP | 4 | $85 |
| ABBVIE INC. | 3 | $51 |
| Tris Pharma Inc | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: Jornay PM, Qelbree, Azstarys, Adzenys XR-ODT, VRAYLAR, Dyanavel XR, Auvelity, CAPLYTA.
Industry payments across OH — which companies pay providers there.
